Galt Pharms Drug Patent Portfolio
Galt Pharms owns 2 orange book drugs protected by 4 US patents Given below is the list of Galt Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7608616 | Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia | 03 Jun, 2028 | Active |
| US6916485 | Prolonged release bioadhesive therapeutic systems | 11 Sep, 2022 | Expired |
| US7651698 | Prolonged release bioadhesive therapeutic systems | 11 Sep, 2022 | Expired |
| US8518442 | Prolonged release bioadhesive therapeutic systems | 11 Sep, 2022 | Expired |
Latest Legal Activities on Galt Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Galt Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 29 Nov, 2021 | US7608616 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 23 Jun, 2021 | US7651698 |
|
Maintenance Fee Reminder Mailed
Critical
| 14 Jun, 2021 | US7608616 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 21 Jan, 2021 | US8518442 |
|
Email Notification
Critical
| 25 Nov, 2015 | US7608616 |
| Mail-Petition Decision - Granted | 17 Nov, 2015 | US7608616 |
|
Petition Decision - Granted
Critical
| 16 Nov, 2015 | US7608616 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 10 Nov, 2015 | US7608616 |
| Petition Entered | 13 Aug, 2015 | US7608616 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Aug, 2013 | US8518442 |
|
Recordation of Patent Grant Mailed
Critical
| 27 Aug, 2013 | US8518442 |
|
Email Notification
Critical
| 08 Aug, 2013 | US8518442 |
|
Issue Notification Mailed
Critical
| 07 Aug, 2013 | US8518442 |
| Dispatch to FDC | 30 Jul, 2013 | US8518442 |
|
Application Is Considered Ready for Issue
Critical
| 26 Jul, 2013 | US8518442 |
Galt Pharms's Family Patents
Galt Pharms Drug List
Given below is the complete list of Galt Pharms's drugs and the patents protecting them.
1. Doral
Doral is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7608616 | Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia |
03 Jun, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Doral's drug page
2. Oravig
Oravig is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6916485 | Prolonged release bioadhesive therapeutic systems |
11 Sep, 2022
(2 years ago)
| Expired |
| US7651698 | Prolonged release bioadhesive therapeutic systems |
11 Sep, 2022
(2 years ago)
| Expired |
| US8518442 | Prolonged release bioadhesive therapeutic systems |
11 Sep, 2022
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Oravig's drug page